Parkwood LLC’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-1,077
Closed -$248K 588
2016
Q3
$248K Sell
1,077
-13,459
-93% -$3.29M 0.04% 446
2016
Q2
$3.36M Buy
14,536
+5,159
+55% +$1.19M 0.56% 47
2016
Q1
$2.51M Sell
9,377
-3,537
-27% -$1.01M 0.42% 52
2015
Q4
$4.04M Sell
12,914
-357
-3% -$106K 0.64% 33
2015
Q3
$3.61M Sell
13,271
-3,569
-21% -$1.1M 0.59% 36
2015
Q2
$5.11M Buy
+16,840
New +$5.02M 0.72% 25

Other funds holding AGN

Parkwood LLC's AGN Position: Q4 2016 in Review

Parkwood LLC sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 1,077 shares — an estimated $248K sold.

Parkwood LLC first reported a position in AGN in Q2 2015 and held it in 6 quarters. The position peaked at $5.11M in Q2 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Parkwood LLC reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Parkwood LLC sold 1,077 Allergan plc shares in Q4 2016, an estimated $248K.
  • Parkwood LLC first reported a position in Allergan plc in Q2 2015 and held it in 6 quarters.
  • Parkwood LLC's Allergan plc position peaked at $5.11M in Q2 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Parkwood LLC's 13F filing for Q4 2016, filed 27 Jan 2017.